多囊卵巢综合征女性胚胎异常风险是否增加?一项多中心随机对照试验的二次分析
该研究为多中心随机对照试验的二次分析,纳入14个生殖中心的190例多囊卵巢综合征(PCOS)患者与1:1年龄匹配的非PCOS患者,共380例患者、1118枚胚胎。调整潜在混杂因素后,PCOS组胚胎非整倍体率和嵌合体率与对照组无显著差异,各PCOS表型间亦无显著差异。
要点
- PCOS组胚胎非整倍体率14.0% vs 对照组18.3%,调整OR 0.78(95%CI 0.54-1.12),P=0.19。
- PCOS组胚胎嵌合体率10.9% vs 对照组10.1%,调整OR 0.91(95%CI 0.59-1.40),P=0.66。
- 按PCOS表型分层后,各表型与对照组间胚胎非整倍体和嵌合体率均无显著差异。
核心结论
- PCOS女性胚胎非整倍体和嵌合体风险未增加,因此作者建议PCOS与非PCOS女性因胚胎染色体异常导致的流产率可能相似。
研究设计与样本
- 多中心随机对照试验的二次分析,于2017年7月至2018年6月进行,从14个生殖中心PGT-A组中选取190例PCOS患者和1:1年龄匹配的非PCOS患者,共380例患者、1118枚胚胎。
主要发现
- 调整潜在混杂因素后,PCOS组胚胎非整倍体率14.0% vs 对照组18.3%,调整OR 0.78(95%CI 0.54-1.12),P=0.19。
- PCOS组胚胎嵌合体率10.9% vs 对照组10.1%,调整OR 0.91(95%CI 0.59-1.40),P=0.66。
- 按PCOS表型分为4组后,各表型与对照组间胚胎非整倍体和嵌合体率均无显著差异,4种表型间亦无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Some studies have reported the early miscarriage rate is higher in polycystic ovary syndrome (PCOS) women. However, there is a lack of evidence as to whether the risk of embryo abnormalities increases in PCOS women. OBJECTIVE: This work aimed to evaluate the association between PCOS and embryo ploidy. METHODS: A secondary analysis of a multicenter, randomized controlled trial was conducted from July 2017 to June 2018. The original intent was to identify whether preimplantation genetic test for aneuploidy (PGT-A) improves the live birth rate as compared with in vitro fertilization (IVF). From 14 reproductive centers, 190 patients diagnosed with PCOS and 1:1 age-matched non-PCOS patients were chosen from a PGT-A group. A total of 380 patients with 1118 embryos were included in our study. Intervention included women diagnosed with PCOS, and the main outcome measures were embryonic aneuploidy and embryonic mosaic. RESULTS: After adjusting for potential confounders, the rate of embryonic aneuploidy and embryonic mosaic in the PCOS group were comparable with the control group (embryonic aneuploid rate PCOS group: 14.0% vs control group: 18.3%, adjusted OR [95% CI]: 0.78 [0.54, 1.12]; P = .19; embryonic mosaic rate 10.9% vs 10.1%, adjusted OR [95% CI]: 0.91 [0.59, 1.40]; P = .66). We further stratified PCOS women into 4 groups according to phenotype. The rate of aneuploid and mosaic embryos was comparable between each PCOS phenotype and control group. There was still no significant difference of embryonic aneuploid and embryo mosaic rates among the 4 phenotypes. CONCLUSION: The risk of aneuploid and mosaic embryos did not increase in PCOS women. Thus, we suggest that the miscarriage rate arising from abnormal embryonic chromosomes could be similar between PCOS and non-PCOS women.
引用
- Wang J, Zhou W, Song Z, et al. Does the Risk of Embryo Abnormality Increase in PCOS Women? A Secondary Analysis of a Multicenter, Randomized Controlled Trial. J Clin Endocrinol Metab. 2023. PMID: 36546342. doi:10.1210/clinem/dgac726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。